P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

Detalles Bibliográficos
Autores principales: Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012127/
http://dx.doi.org/10.1097/01.HS9.0000829640.69738.dc
_version_ 1784687737098469376
author Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
author_facet Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
author_sort Mele, G
collection PubMed
description
format Online
Article
Text
id pubmed-9012127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90121272022-04-18 P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE” Mele, G Cascavilla, N Di Renzo, N Guarini, A Mazza, P Melillo, L Pavone, V Tarantini, G Curci, P Falcone, AP Germano, C Mele, A Palazzo, G Palumbo, G Reddiconto, G Rossini, B Specchia, G Musto, P Pastore, D Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9012127/ http://dx.doi.org/10.1097/01.HS9.0000829640.69738.dc Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_full P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_fullStr P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_full_unstemmed P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_short P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_sort p17: daratumumab (d) plus lenalidomide (r) and dexamethasone (d) as salvage therapy for patients with refractory-relapsed multiple myeloma (rrmm): initial follow-up of an italian multicenter retrospective clinical experience by “rete ematologica pugliese”
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012127/
http://dx.doi.org/10.1097/01.HS9.0000829640.69738.dc
work_keys_str_mv AT meleg p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT cascavillan p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT direnzon p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT guarinia p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT mazzap p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT melillol p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT pavonev p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT tarantinig p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT curcip p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT falconeap p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT germanoc p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT melea p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT palazzog p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT palumbog p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT reddicontog p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT rossinib p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT specchiag p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT mustop p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT pastored p17daratumumabdpluslenalidomideranddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese

Ejemplares similares